Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:13 pm Unchanged | 2020-12-31 | 13G | VYNE Therapeutics Inc. VYNE | Great Point Partners, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-07-07 5:27 pm Purchase | 2020-07-07 | 13G | Abeona Therapeutics Inc. ABEO | Great Point Partners, LLC | 339,555 9.990% | 336 (+0.10%) | Filing History |
| 2020-06-05 5:00 pm Purchase | 2020-05-26 | 13G | Constellation Pharmaceuticals, Inc. CNST | Great Point Partners, LLC | 2,301,457 5.500% | 2,301,457 (New Position) | Filing History |
| 2020-06-01 5:15 pm Purchase | 2020-05-22 | 13G | Geron Corporation GERN | Great Point Partners, LLC | 23,097,117 7.300% | 23,097,117 (New Position) | Filing History |
| 2020-04-22 5:17 pm Purchase | 2020-04-21 | 13D | Abeona Therapeutics Inc. ABEO | Great Point Partners, LLC | 339,219 9.990% | 820 (+0.24%) | Filing History |